U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Northpond Ventures II, LP (0001869128)
State location: MD | State of Inc.: DE | Fiscal Year End: 1231
Business Address
7500 OLD GEORGETOWN ROAD
SUITE 800
BETHESDA MD 20814
240-800-1200
Mailing Address
7500 OLD GEORGETOWN ROAD
SUITE 800
BETHESDA MD 20814
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Camp4 Therapeutics Corp 0001736730 2024-10-10 10 percent owner
Vigil Neuroscience, Inc. 0001827087 2022-01-06 10 percent owner
DICE Therapeutics, Inc. 0001645569 2021-09-14 10 percent owner
Codex DNA, Inc.
Current Name:Telesis Bio Inc.
0001850079 2021-06-22 10 percent owner


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016